222 related articles for article (PubMed ID: 7986084)
21. Role of Ser457 of NADPH-cytochrome P450 oxidoreductase in catalysis and control of FAD oxidation-reduction potential.
Shen AL; Kasper CB
Biochemistry; 1996 Jul; 35(29):9451-9. PubMed ID: 8755724
[TBL] [Abstract][Full Text] [Related]
22. The NH2-terminal region of rabbit CYP2E1 is not essential for interaction with NADPH-cytochrome P450 reductase.
Voznesensky AI; Schenkman JB; Pernecky SJ; Coon MJ
Biochem Biophys Res Commun; 1994 Aug; 203(1):156-61. PubMed ID: 8074649
[TBL] [Abstract][Full Text] [Related]
23. Flavin-binding and protein structural integrity studies on NADPH-cytochrome P450 reductase are consistent with the presence of distinct domains.
Narayanasami R; Horowitz PM; Masters BS
Arch Biochem Biophys; 1995 Jan; 316(1):267-74. PubMed ID: 7840627
[TBL] [Abstract][Full Text] [Related]
24. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
Murataliev MB; Klein M; Fulco A; Feyereisen R
Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
[TBL] [Abstract][Full Text] [Related]
25. Oxidative cleavage of esters and amides to carbonyl products by cytochrome P450.
Peng HM; Raner GM; Vaz AD; Coon MJ
Arch Biochem Biophys; 1995 Apr; 318(2):333-9. PubMed ID: 7733661
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the FAD binding domain of cytochrome P450 reductase.
Hodgson AV; Strobel HW
Arch Biochem Biophys; 1996 Jan; 325(1):99-106. PubMed ID: 8554349
[TBL] [Abstract][Full Text] [Related]
27. The closed and compact domain organization of the 70-kDa human cytochrome P450 reductase in its oxidized state as revealed by NMR.
Vincent B; Morellet N; Fatemi F; Aigrain L; Truan G; Guittet E; Lescop E
J Mol Biol; 2012 Jul; 420(4-5):296-309. PubMed ID: 22543241
[TBL] [Abstract][Full Text] [Related]
28. [Kinetics of adrenodoxin reductase oxidation by non-physiologic electron acceptors].
Chenas NK; Martsinkiavichene IA; Kulis IuIu; Usanov SA
Biokhimiia; 1987 Apr; 52(4):643-9. PubMed ID: 3593793
[TBL] [Abstract][Full Text] [Related]
29. The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain.
Estabrook RW; Shet MS; Fisher CW; Jenkins CM; Waterman MR
Arch Biochem Biophys; 1996 Sep; 333(1):308-15. PubMed ID: 8806785
[TBL] [Abstract][Full Text] [Related]
30. The rotenone-insensitive reduction of quinones and nitrocompounds by mitochondrial NADH:ubiquinone reductase.
Bironaite DA; Cenas NK; Kulys JJ
Biochim Biophys Acta; 1991 Oct; 1060(2):203-9. PubMed ID: 1932041
[TBL] [Abstract][Full Text] [Related]
31. Biochemical characteristics of purified beef liver NADPH-cytochrome P450 reductase.
Arinç E; Celik H
J Biochem Mol Toxicol; 2002; 16(6):286-97. PubMed ID: 12481304
[TBL] [Abstract][Full Text] [Related]
32. Quinone- and nitroreductase reactions of Thermotoga maritima peroxiredoxin-nitroreductase hybrid enzyme.
Anusevičius Ž; Misevičienė L; Šarlauskas J; Rouhier N; Jacquot JP; Čėnas N
Arch Biochem Biophys; 2012 Dec; 528(1):50-6. PubMed ID: 22982531
[TBL] [Abstract][Full Text] [Related]
33. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
34. Affinity isolation and characterization of cytochrome P450 102 (BM-3) from barbiturate-induced Bacillus megaterium.
Black SD; Linger MH; Freck LC; Kazemi S; Galbraith JA
Arch Biochem Biophys; 1994 Apr; 310(1):126-33. PubMed ID: 8161195
[TBL] [Abstract][Full Text] [Related]
35. Nitroreductase reactions of the NADPH: adrenodoxin reductase and the adrenodoxin complex.
Marcinkeviciene J; Cenas N; Kulys J; Usanov SA; Sukhova NM; Selezneva IS; Gryazev VF
Biomed Biochim Acta; 1990; 49(4):167-72. PubMed ID: 2403337
[TBL] [Abstract][Full Text] [Related]
36. Residue 285 in cytochrome P450 2B4 lacking the NH(2)-terminal hydrophobic sequence has a role in the functional association of NADPH-cytochrome P450 reductase.
Schulze J; Tschöp K; Lehnerer M; Hlavica P
Biochem Biophys Res Commun; 2000 Apr; 270(3):777-81. PubMed ID: 10772901
[TBL] [Abstract][Full Text] [Related]
37. Functional interactions in cytochrome P450BM3. Fatty acid substrate binding alters electron-transfer properties of the flavoprotein domain.
Murataliev MB; Feyereisen R
Biochemistry; 1996 Nov; 35(47):15029-37. PubMed ID: 8942669
[TBL] [Abstract][Full Text] [Related]
38. Structure and function of NADPH-cytochrome P450 reductase and nitric oxide synthase reductase domain.
Iyanagi T
Biochem Biophys Res Commun; 2005 Dec; 338(1):520-8. PubMed ID: 16125667
[TBL] [Abstract][Full Text] [Related]
39. Lucigenin as a substrate of microsomal NAD(P)H-oxidoreductases.
Schepetkin IA
Biochemistry (Mosc); 1999 Jan; 64(1):25-32. PubMed ID: 9986909
[TBL] [Abstract][Full Text] [Related]
40. NADPH-cytochrome P-450 reductase. Physical properties and redox behavior in the absence of the FAD moiety.
Kurzban GP; Howarth J; Palmer G; Strobel HW
J Biol Chem; 1990 Jul; 265(21):12272-9. PubMed ID: 2115516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
